Janet Wozniak
Harvard University
168 Papers
1.1K Citations
Janet Wozniak is an academic researcher from Harvard University. The author has contributed to research in topics: Bipolar disorder & Mania. The author has an hindex of 57, co-authored 154 publications. Previous affiliations of Janet Wozniak include Medical University of Łódź & Massachusetts Mental Health Center.
Chat about Author
Papers
Can a subtype of conduct disorder linked to bipolar disorder be identified? Integration of findings from the Massachusetts General Hospital Pediatric Psychopharmacology Research Program.
Joseph Biederman,Eric Mick,Janet Wozniak,Michael C. Monuteaux,Maribel Galdo,Stephen V. Faraone +5 more
TL;DR: Results from a series of programmatic studies examining phenotypic features of bipolar and conduct disorder alone or combined in probands and relatives showed that children with CD and BPD had similar features of each disorder irrespective of the comorbidity with the other disorder.
75
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.
Joseph Biederman,Eric Mick,Thomas J. Spencer,Robert Doyle,Gagan Joshi,Paul Hammerness,Megan Kotarski,Megan Aleardi,Janet Wozniak +8 more
TL;DR: Open-label aripiprazole treatment was beneficial in the treatment of mania in youth with bipolar disorder and future placebo-controlled, double blind studies are warranted.
74
•Journal Article
Diagnostic and therapeutic dilemmas in the management of pediatric-onset bipolar disorder.
TL;DR: Research regarding the atypical presentation of pediatric bipolar disorder and its overlap with attention-deficit/hyperactivity disorder and other comorbid conditions, as well as family-genetic and treatment data are summarized.
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder.
Joseph Biederman,Gagan Joshi,Eric Mick,Robert Doyle,Anna M. Georgiopoulos,Paul Hammerness,Meghan Kotarski,Courtney Williams,Janet Wozniak +8 more
TL;DR: Open‐label lamotrigine treatment appears to be beneficial in the treatment of bipolar disorder and associated conditions in children and future placebo‐controlled, double‐blind studies are warranted to confirm these findings.
Parsing the association between bipolar, conduct, and substance use disorders: a familial risk analysis.
TL;DR: The combination of conduct disorder + bipolar disorder in youth predicts especially high rates of substance use disorders in relatives, which supports previous results documenting that when bipolar disorder and conduct disorder occur comorbidly, both are validly diagnosed disorders.
68